How to improve treatment persistence in fibrosing ILD patients on nintedanib, without sacrificing effectiveness? A possible answer from Japan
Francesco Bonella, Sebastian Majewski; How to improve treatment persistence in fibrosing ILD patients on nintedanib, without sacrificing effectiveness? A p
Authors
- Sebastian Majewski
- Francesco Bonella
Institutions
- Ruhrlandklinik (DE)
- Medical University of Lodz (PL)
Publication Details
- Journal
- Annals of the American Thoracic Society
- Published
- 2026-08-17
- DOI
- https://doi.org/10.1093/annalsats/aaoag133
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00